TRIAL DETAIL

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Drug:
Trial Name:
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
NCT#:
Conditions:
Brain and Central Nervous System Tumors; Gastrointestinal Stromal Tumor; Ovarian Cancer; Sarcoma; Small Intestine Cancer
Status:
Completed
Phase:
2
Start Date
Age of Trial (yrs)
Treatment Phase:
First-line
Drug Category:
Chemotherapy
Strategy:
Traditional chemotherapy
Trial Type:
Specifically GIST plus other cancers
Other Protocol IDs:
CDR0000067132, EORTC-62982
Sponsor:
EORTC
Patient Contact:
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Intravenous
Trial Notes:
This study is ongoing but not recruiting new patients. Results reported in 2004 suggest that it is not an effective treatment for advanced GIST.

Trial Links

Trial Results

 
 

Drug Information

NCI Drug Dictionary
 
Full text article- PK and PD of the novel marine-derived anticancer agent Ecteinascidin 743 in a phase I dose-finding study
 

Trial Sites

Name
Address
City
State
Zip
Country